Latest in Ingredients

Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription

With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Industrial data mastery: navigating the 2025 landscape

As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
See more

Europa Biosite acquires life science product and service supplier, AMSBIO

Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens

Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability

The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Logical Biological expands its raw pharma material development and supply capabilities with new lab

The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity

Biosynth inaugurates its Biological Technology site in Suzhou, China

The new site will serve the Chinese domestic market, providing raw materials for vaccines and pharmaceuticals, while dealing regional distribution and handling

Seppic launches surfactant excipient for the optimisation of biological formulations

The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Ingredients

Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024

galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals

Indena showcases its CDMO services and HPAPI capabilities at CPHI 2024

The company will display its range of high-potency APIs, as well as its ADC and linker payload development and manufacturing capabilities

Clariant introduces new high-performing excipients at the CPHI Milan 2024 trade show

Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI trade show in Milan

IFF Pharma Solutions brings new innovations and excipient excellence to CPHI 2024

IFF Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries

Agarose Bead Technologies expands its Spanish agarose resin manufacturing facility

The site is now capable of producing 100,000L of agarose resin per year, which pharma and bioprocessing professionals can use for CGT purification purposes

Bioiberica presents its potent API solutions at CPHI Milan

The company will be on hand to discuss its APIs and ingredients for pharmaceutical products, as well as its circular economy model

dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan

The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient

Sigrid Therapeutics' Glucose Stabiliser listed on US e-commerce site, GetHealthy.store

The non-pharmaceutical silica solution can assist patients in managing their blood sugar, while reducing bloating and increasing energy levels

CPHI Milan Annual Report 2024

Ahead of next month’s CPHI Milan — where the industry is expected to turnout in record numbers with a staggering 62,000 pharma executives expected from more than 100 countries — Manufacturing Chemist got a sneak preview of the CPHI Annual Reports Excipients Analysis featuring Ian Moore’s (former Chair of the IPEC Europe GMP Committee) personal predictions for the year ahead

The promising future of GLP-1s and oral peptides

Dr Andy Lewis, Chief Scientific Officer at Quotient Sciences, examines the trends driving the adoption of oral peptide products and discusses strategies to overcome the development challenges associated with effective delivery

The rise of nutraceuticals in the pharmaceutical industry

Driven by current market and consumer trends, pharmaceutical companies are increasingly embracing nutraceutical ingredients such as astaxanthin

Barentz acquires Anshul Life Sciences to bolster presence in the Indian market

The strategic acquisition will allow Barentz to distribute its pharmaceutical ingredients to India, a key location for market growth currently

Sponsor content

Therapeutic: felzartamab for kidney disease

Immunoglobulin A nephropathy (IgAN) or Berger disease is the most common form of primary glomerulonephritis and a leading cause of chronic kidney disease

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene

Therapeutic: brensocatib for bronchiectasis

The chronic lung disease bronchiectasis is a serious condition in which the bronchi become permanently dilated because of a cycle of infection, inflammation and damage to...

New small-scale In-Line mixer range from Silverson Machines

Silverson launches versatile small-scale mixers for pharma and biotech applications

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Therapeutic: anticancer agent ivonescimab

The advent of PD-1 and PD-L1 targeting antibodies has transformed the outlook for many cancer patients by harnessing the body’s immune system to fight tumour cells

Therapeutic: seladelpar for primary biliary cholangitis

The chronic and progressive autoimmune liver disease, primary biliary cholangitis, affects the bile ducts running through the liver and slowly degrades them

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers

ICROM has acquired HOLODIAG

ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services...

Olon continues its growth with a new acquisition

The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence

Featured companies

At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a... Contract development and manufacturing of Potent and non Potent APIs Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug... Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or...
See more